CARDIOCELL

cardiocell-logo

Founded in San Diego, Calif., in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under cGMP conditions. CardioCell has an exclusive worldwide license from its parent company, Stemedica, for exploration of therapeutic indications in the cardiovascular field, which includes such indications as acute myocardial Infarction (AMI), chronic heart failure (CHF) and peripheral artery disease (PAD).

#SimilarOrganizations #People #Website #More

CARDIOCELL

Industry:
Biotechnology Clinical Trials Health Care

Founded:
2013-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.stemcardiocell.com

Total Employee:
1+

Status:
Active

Contact:
(858) 875-6569

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Microsoft Exchange Online


Similar Organizations

acs-global-logo

ACS Global

ACS Global offers services for individuals to privately preserve their stem cells for potential future use in cell therapy.


Current Advisors List

leo-spiegel_image

Leo Spiegel Board Member @ CardioCell
Board_member
2013-05-01

leo-speigel_image

Leo Speigel Board Member @ CardioCell
Board_member
2013-05-01

Current Employees Featured

sergey-sikora_image

Sergey Sikora
Sergey Sikora Co-founder & CEO @ CardioCell
Co-founder & CEO

Founder


sergey-sikora_image

Sergey Sikora

Official Site Inspections

http://www.stemcardiocell.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K

  • Host name: 104.21.44.141
  • IP address: 104.21.44.141
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "CardioCell"

CardioCell - 2025 Company Profile & Team - Tracxn

CardioCell - Mesenchymal stem cells based therapy for different cardiovascular indications such as acute myocardial infarction.. Raised a total funding of $1.06M over 1 round.See details»

CardioCell Company Profile | Management and Employees List

CardioCell Profile and History Founded in San Diego, California, in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique, patented, โ€ฆSee details»

CardioCell - Overview, News & Similar companies | ZoomInfo.com

View CardioCell (www.stemcardiocell.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much โ€ฆSee details»

stemcardiocell.com

Stemcardiocell.comSee details»

CardioCell - LinkedIn

About us Website http://stemcardiocell.com Industry Biotechnology Company size 2-10 employees Headquarters San Diego, CASee details»

CardioCell 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for CardioCell. Use the PitchBook Platform to explore the full profile.See details»

CardioCell - Crunchbase Company Profile & Funding

CardioCell is currently in clinical trials using stem cells to develop highly effective, โ€œoff-the-shelfโ€ therapeutic products.See details»

Cardiocell LLC - Drug pipelines, Patents, Clinical trials - Synapse

Explore Cardiocell LLC with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news, and 1 literature, Drug:Mesenchymal stem cell therapy (Stemedica Cell โ€ฆSee details»

CardioCell Company Profile - Craft

See insights on CardioCell including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

CardioCell (Stemedica) - Regenerative Medicine Now

CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under โ€ฆSee details»

CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for ...

Dec 1, 2015 For more information, visit www.stemcardiocell.com. About Stemedica Cell Technologies, Inc. Stemedica Cell Technologies, Inc. is a global biopharmaceutical company โ€ฆSee details»

New Stem Cell Therapy May Transform Heart Failure Treatment

Washington, D.C., April 18, 2018 โ€“ Clinical trial planning is underway at MedStar Heart & Vascular Institute to determine whether a novel stem cell therapy will improve heart function โ€ฆSee details»

Cardiac stem cells: Current knowledge and future prospects

Regenerative medicine is the field concerned with the repair and restoration of the integrity of damaged human tissues as well as whole organs. Since the inception of the field several โ€ฆSee details»

CardioCell stem cells โ€˜improve well-beingโ€™ of heart failure patients

Aug 29, 2016 Since Celyad failed to reach its primary endpoints in a stem cell therapy test in heart patients back in June, CardioCell has felt the pressure to deliver and over the weekend โ€ฆSee details»

Stem cells and the heartโ€”the road ahead - Science | AAAS

Feb 21, 2020 Heart disease is the primary cause of death worldwide, principally because the heart has minimal ability to regenerate muscle tissue. Myocardial infarction (heart attack) โ€ฆSee details»

CardioCell Completes Enrollment For A Phase IIa Clinical

For more information, visit www.stemcardiocell.com. About Stemedica Cell Technologies Inc. Stemedica Cell Technologies Inc. is a global biopharmaceutical company that manufactures โ€ฆSee details»

Stem cell therapy for cardiac regeneration: past, present, and future

Cardiac disorders remain the leading cause of mortality worldwide. Current clinical strategies, including drug therapy, surgical interventions, and organ transplantation offer limited benefits โ€ฆSee details»

Cardiac stem cell biology: a glimpse of the past, present, and future

Cardiac regeneration strategies and de novo generation of cardiomyocytes have long been significant areas of research interest in cardiovascular medicine. In this review, we outline a โ€ฆSee details»

The Adult Cardiac Stem Cell Concept and the Process of Science

One theory of the mammalian heart has been that cardiomyocytes arose from adult stem cells marked by the cell surface protein Sca-1. In this issue of Circulation, five reports from different โ€ฆSee details»

Cardioids reveal self-organizing principles of human cardiogenesis

May 20, 2021 However, existing models do not recapitulate cardiac-specific self-organization to acquire in vivo -like architecture such as a CM chamber with inner endocardial cavity lining โ€ฆSee details»

linkstock.net © 2022. All rights reserved